1. Home
  2. ANGI vs AVXL Comparison

ANGI vs AVXL Comparison

Compare ANGI & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Angi Inc.

ANGI

Angi Inc.

HOLD

Current Price

$4.86

Market Cap

180.9M

ML Signal

HOLD

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$3.25

Market Cap

237.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANGI
AVXL
Founded
1995
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
180.9M
237.2M
IPO Year
2017
2013

Fundamental Metrics

Financial Performance
Metric
ANGI
AVXL
Price
$4.86
$3.25
Analyst Decision
Buy
Strong Buy
Analyst Count
7
3
Target Price
$17.00
$22.00
AVG Volume (30 Days)
841.9K
902.2K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
1242.86
N/A
EPS
N/A
N/A
Revenue
$736,386,000.00
N/A
Revenue This Year
$3.25
N/A
Revenue Next Year
$3.76
N/A
P/E Ratio
N/A
N/A
Revenue Growth
47.60
N/A
52 Week Low
$4.26
$2.26
52 Week High
$18.70
$10.40

Technical Indicators

Market Signals
Indicator
ANGI
AVXL
Relative Strength Index (RSI) 45.12 58.78
Support Level $4.57 $2.93
Resistance Level $6.52 $3.53
Average True Range (ATR) 0.34 0.17
MACD -0.01 -0.01
Stochastic Oscillator 28.35 54.33

Price Performance

Historical Comparison
ANGI
AVXL

About ANGI Angi Inc.

Angi Inc connects quality home service professionals with consumers across different categories, from repairing and remodeling to cleaning and landscaping. It operates through brands like Angi, HomeAdvisor, and Handy. The company has three operating segments, namely, Ads and Leads, Services, and International (Europe and Canada). A majority of its revenue is generated from the Ads and Leads segment, which provides professionals the capability to engage with potential customers, including quoting and invoicing services, and provides consumers with tools and resources to help them find professionals nationwide for home repair, maintenance, and improvement projects. Geographically, the company derives its key revenue from the United States and also has a presence in other countries.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: